[(ALKYLAMINO)METHYL]ACRYLOPHENONES - POTENT AND SELECTIVE INHIBITORS OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR PROTEIN-TYROSINE KINASE

被引:94
作者
TRAXLER, P
TRINKS, U
BUCHDUNGER, E
METT, H
MEYER, T
MULLER, M
REGENASS, U
ROSEL, J
LYDON, N
机构
[1] CIBA Pharmaceuticals Division, Cancer and Infectious Disease Research Department, CIBA Limited
关键词
D O I
10.1021/jm00013a020
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[(Alkylamino)methyl]acrylophenones and (alkylamino)propiophenones, bearing a spacer moiety such as the benzyloxy or (benzoylsulfonyl)oxy group in the 4-position, represent a novel class of inhibitors of the epidermal growth factor (EGF) receptor protein tyrosine kinase with a high degree of selectivity versus other tyrosine and serine/threonine kinases. The most active compounds inhibited the EGF receptor protein tyrosine kinase from A431 cell membranes with IC50 values of <0.5 mu M. Derivatives with a benzyloxy substituent in the 4-position of the aromatic ring inhibited both the EGF receptor kinase and the proliferation of an EGF-dependent mouse epidermal keratinocyte cell line (BALB/MK) but were only marginally active in the inhibition of the cellular EGF-dependent tyrosine phosphorylation. Compound 18 inhibited ligand-induced tyrosine phosphorylation and BALB/MK cell proliferation with IC50 values of approximately 100 and 1.21 mu M, respectively, and showed antitumor activity in vivo in a nude mouse model. However, the discrepancy between the IC50 values for antiproliferative activity and cellular tyrosine phosphorylation as well as the relatively low tolerability in animals suggests a second site of action of this class of inhibitors. Nevertheless, [(alkylamino)methyl]acrylophenones and (alkylamino)propiophenones may prove to be interesting tools for studying the action of tyrosine kinases.
引用
收藏
页码:2441 / 2448
页数:8
相关论文
共 45 条
[1]   GROWTH-FACTORS AND CANCER [J].
AARONSON, SA .
SCIENCE, 1991, 254 (5035) :1146-1153
[2]  
BARKER AJ, 1994, ANN ONCOL, V5, P120
[3]  
BUCHDUNGER E, 1992, P NATL ACAD SCI USA, V91, P2334
[4]  
BURKE T R JR, 1992, Drugs of the Future, V17, P119
[5]   BICYCLIC COMPOUNDS AS RING-CONSTRAINED INHIBITORS OF PROTEIN-TYROSINE KINASE-P56LCK [J].
BURKE, TR ;
LIM, B ;
MARQUEZ, VE ;
LI, ZH ;
BOLEN, JB ;
STEFANOVA, I ;
HORAK, ID .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (04) :425-432
[6]  
CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.bi.56.070187.004313
[7]   SYNTHESIS AND STRUCTURE-ACTIVITY STUDIES OF A SERIES OF [(HYDROXYBENZYL)AMINO]SALICYLATES AS INHIBITORS OF EGF RECEPTOR-ASSOCIATED TYROSINE KINASE-ACTIVITY [J].
CHEN, HX ;
BOIZIAU, J ;
PARKER, F ;
MAROUN, R ;
TOCQUE, B ;
ROQUES, BP ;
GARBAYJAUREGUIBERRY, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (25) :4094-4098
[8]   REQUIREMENT FOR INTRINSIC PROTEIN TYROSINE KINASE IN THE IMMEDIATE AND LATE ACTIONS OF THE EGF RECEPTOR [J].
CHEN, WS ;
LAZAR, CS ;
POENIE, M ;
TSIEN, RY ;
GILL, GN ;
ROSENFELD, MG .
NATURE, 1987, 328 (6133) :820-823
[9]   SYNTHESES AND EVALUATION OF SOME MANNICH-BASES DERIVED FROM ACETOPHENONES AGAINST P388 LYMPHOCYTIC-LEUKEMIA AND TOXICOLOGICAL ASSESSMENT OF 3-DIMETHYLAMINO-2-DIMETHYLAMINOMETHYL-1-(4-METHOXYPHENYL)-1-PROPANONE DIHYDROCHLORIDE IN RATS [J].
DIMMOCK, JR ;
SHYAM, K ;
LOGAN, BM ;
SMITH, PJ ;
CROSS, BM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (04) :471-477
[10]   EVALUATION OF ACRYLOPHENONES AND RELATED BIS-MANNICH BASES AGAINST MURINE P388 LEUKEMIA [J].
DIMMOCK, JR ;
PATIL, SA ;
LEEK, DM ;
WARRINGTON, RC ;
FANG, WD .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1987, 22 (06) :545-551